Symposium on drug safety. The role of regulatory agencies and industry in assessment of the safety of drugs for use in man. The situation in the United Kingdom.
作者信息
Cahal D A
出版信息
Can Med Assoc J. 1968 Feb 10;98(6):271-5.
Abstract
摘要
相似文献
1
2
Clinical pharmacology in the United Kingdom.
Clin Pharmacol Ther. 1974 Sep;16(3):605-15. doi: 10.1002/cpt1974163part2605.
3
[Pharmacovigilance in the framework of recording and control of drugs in the United Kingdom].
Therapie. 1974 Nov-Dec;29(6):799-804.
4
Adverse drug reactions. A problem for drug regulatory agencies.
Int J Clin Pharmacol. 1973 Apr;7(2):183-9.
5
Communicating adverse drug reactions.报告药品不良反应
Lancet. 1978 Jan 21;1(8056):133.
6
Crying wolf on drug safety.在药物安全问题上谎报险情。
Br Med J (Clin Res Ed). 1982 Jan 23;284(6311):219-20.
7
Discussion on control of new drugs.
Practitioner. 1971 Apr;206(234):546-50.
8
Drugs and the Washington climate.药物与华盛顿的气候。
Trans Am Clin Climatol Assoc. 1969;80:196-204.
9
Present attitudes of governmental drug regulatory agencies.政府药品监管机构目前的态度。
Int J Clin Pharmacol. 1973 Apr;7(2):168-77.
10
Present status of clinical pharmacology and of regulatory requirements for preclinical and clinical evaluation of new drugs in Japan.
Clin Pharmacol Ther. 1974 Sep;16(3):577-84. doi: 10.1002/cpt1974163part2577.
Zotero 插件